Altimmune Inc (ALT)
NASDAQ:ALT
Holding ALT?
Track your performance easily

Altimmune (ALT) Financial Statements

2,957 Followers

Altimmune Financial Overview

Altimmune's market cap is currently ―. The company's EPS TTM is $-1.618; its P/E ratio is -4.19; Altimmune is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 5.00K$ 5.00K$ 37.00K$ 362.00K$ 6.00K
Gross Profit$ 5.00K$ 5.00K$ 37.00K$ 362.00K$ 6.00K
EBIT$ -24.64M$ -24.39M$ -31.64M$ -20.64M$ -16.06M
EBITDA$ -23.60M$ -24.29M$ -29.75M$ -20.64M$ -16.06M
Net Income Common Stockholders$ -24.64M$ -24.39M$ -31.64M$ -20.67M$ -16.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 164.91M$ 182.02M$ 197.81M$ 140.78M$ 160.00M
Total Assets$ 173.35M$ 188.36M$ 210.64M$ 166.57M$ 183.32M
Total Debt$ 0.00$ 0.00$ 0.00$ 4.30M$ 4.17M
Net Debt$ -164.91M$ -182.02M$ -197.81M$ -136.47M$ -155.83M
Total Liabilities$ 15.15M$ 11.33M$ 16.54M$ 16.18M$ 15.60M
Stockholders Equity$ 152.53M$ 172.94M$ 194.10M$ 150.40M$ 167.71M
Cash Flow-
Free Cash Flow$ -18.11M$ -16.36M$ -16.53M$ -20.49M$ -19.38M
Operating Cash Flow$ -18.11M$ -16.36M$ -16.53M$ -20.49M$ -19.38M
Investing Cash Flow$ -3.70M$ -39.52M$ -7.96M$ 4.40M$ 3.99M
Financing Cash Flow$ -46.00K$ -261.00K$ 72.75M$ 588.00K$ 13.06M
Currency in USD

Altimmune Earnings and Revenue History

Altimmune Debt to Assets

Altimmune Cash Flow

Altimmune Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis